Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Interleukin-1 | 29 | 2004 | 1252 | 1.190 |
Why?
|
Babesiosis | 7 | 2022 | 92 | 1.190 |
Why?
|
Clofazimine | 1 | 2022 | 41 | 0.780 |
Why?
|
Wound Infection | 2 | 2023 | 243 | 0.750 |
Why?
|
Adjuvants, Immunologic | 6 | 2018 | 998 | 0.690 |
Why?
|
Lasers | 4 | 2018 | 952 | 0.660 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2023 | 704 | 0.580 |
Why?
|
Anti-Infective Agents | 3 | 2023 | 983 | 0.550 |
Why?
|
Vaccines | 4 | 2018 | 842 | 0.540 |
Why?
|
Staphylococcal Infections | 4 | 2023 | 1398 | 0.520 |
Why?
|
Complement Activation | 11 | 1996 | 447 | 0.510 |
Why?
|
Tumor Necrosis Factor-alpha | 24 | 1997 | 4352 | 0.460 |
Why?
|
Photosensitizing Agents | 5 | 2023 | 629 | 0.450 |
Why?
|
Dendritic Cells | 5 | 2018 | 2747 | 0.440 |
Why?
|
HSP70 Heat-Shock Proteins | 4 | 2018 | 394 | 0.420 |
Why?
|
Glucocorticoids | 1 | 2021 | 2167 | 0.390 |
Why?
|
Guillain-Barre Syndrome | 1 | 2013 | 127 | 0.390 |
Why?
|
Skin | 4 | 2018 | 4503 | 0.360 |
Why?
|
Glutathione | 1 | 2013 | 589 | 0.350 |
Why?
|
Herpes Simplex | 1 | 2013 | 470 | 0.340 |
Why?
|
Injections, Intradermal | 3 | 2018 | 117 | 0.330 |
Why?
|
Potassium Iodide | 2 | 2018 | 13 | 0.320 |
Why?
|
Tetracyclines | 2 | 2018 | 64 | 0.300 |
Why?
|
Burns | 8 | 2013 | 1899 | 0.300 |
Why?
|
Erythrocytes | 5 | 2013 | 2418 | 0.290 |
Why?
|
Herpesvirus 1, Human | 1 | 2013 | 743 | 0.290 |
Why?
|
Heterocyclic Compounds | 2 | 2019 | 245 | 0.280 |
Why?
|
Complement C3a | 5 | 2004 | 66 | 0.280 |
Why?
|
Endotoxins | 8 | 1994 | 519 | 0.270 |
Why?
|
Complement Pathway, Alternative | 6 | 1987 | 113 | 0.260 |
Why?
|
Infrared Rays | 3 | 2018 | 249 | 0.260 |
Why?
|
Complement C5a | 10 | 2004 | 100 | 0.240 |
Why?
|
Anaphylatoxins | 1 | 2004 | 21 | 0.230 |
Why?
|
Influenza Vaccines | 3 | 2017 | 781 | 0.230 |
Why?
|
GPI-Linked Proteins | 2 | 2018 | 472 | 0.230 |
Why?
|
Vaccination | 4 | 2018 | 3437 | 0.230 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3238 | 0.220 |
Why?
|
Cancer Vaccines | 3 | 2018 | 1041 | 0.220 |
Why?
|
Vitamin K 3 | 1 | 2023 | 14 | 0.220 |
Why?
|
Anti-Bacterial Agents | 5 | 2023 | 7477 | 0.200 |
Why?
|
Staphylococcus epidermidis | 4 | 1997 | 121 | 0.190 |
Why?
|
Monocytes | 3 | 2004 | 2605 | 0.190 |
Why?
|
Lipopolysaccharides | 13 | 1998 | 2219 | 0.190 |
Why?
|
Biofilms | 2 | 2023 | 634 | 0.180 |
Why?
|
Microbial Sensitivity Tests | 3 | 2023 | 1967 | 0.180 |
Why?
|
Methylene Blue | 2 | 2018 | 156 | 0.180 |
Why?
|
Mast Cells | 2 | 2018 | 1406 | 0.180 |
Why?
|
Leukocytes, Mononuclear | 9 | 1998 | 1854 | 0.180 |
Why?
|
Babesia | 2 | 1998 | 29 | 0.170 |
Why?
|
Mesothelioma | 2 | 2018 | 811 | 0.170 |
Why?
|
Complement C5 | 4 | 1988 | 104 | 0.170 |
Why?
|
Reactive Oxygen Species | 3 | 2023 | 2149 | 0.160 |
Why?
|
Light | 3 | 2020 | 1355 | 0.160 |
Why?
|
Uropathogenic Escherichia coli | 1 | 2018 | 6 | 0.160 |
Why?
|
Photochemotherapy | 3 | 2018 | 830 | 0.150 |
Why?
|
Otitis Media | 1 | 2020 | 288 | 0.150 |
Why?
|
Cystitis, Interstitial | 1 | 1997 | 68 | 0.140 |
Why?
|
Recombinant Proteins | 11 | 2014 | 6514 | 0.140 |
Why?
|
Lasers, Semiconductor | 1 | 2017 | 44 | 0.140 |
Why?
|
Chemokine CXCL12 | 1 | 2019 | 457 | 0.140 |
Why?
|
Lung | 6 | 2013 | 10099 | 0.130 |
Why?
|
Neisseria gonorrhoeae | 1 | 2019 | 249 | 0.130 |
Why?
|
Urticaria | 1 | 1997 | 151 | 0.130 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.130 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 899 | 0.130 |
Why?
|
Platelet Activation | 2 | 1997 | 644 | 0.130 |
Why?
|
Cellulose | 1 | 1996 | 117 | 0.130 |
Why?
|
Mastocytosis | 1 | 1997 | 150 | 0.120 |
Why?
|
Acute-Phase Reaction | 1 | 1995 | 91 | 0.120 |
Why?
|
Babesia microti | 2 | 2006 | 31 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.120 |
Why?
|
Gonorrhea | 1 | 2019 | 355 | 0.120 |
Why?
|
Antibodies, Viral | 3 | 2020 | 3216 | 0.120 |
Why?
|
Sialoglycoproteins | 6 | 2004 | 315 | 0.120 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2819 | 0.120 |
Why?
|
Drug Synergism | 7 | 2018 | 1760 | 0.120 |
Why?
|
Platelet Activating Factor | 1 | 1994 | 143 | 0.120 |
Why?
|
Communicable Diseases, Emerging | 2 | 2014 | 149 | 0.110 |
Why?
|
Avidin | 1 | 2014 | 44 | 0.110 |
Why?
|
Receptors, CXCR4 | 1 | 2019 | 729 | 0.110 |
Why?
|
Membranes, Artificial | 1 | 1996 | 367 | 0.110 |
Why?
|
Immunomodulation | 1 | 2018 | 549 | 0.110 |
Why?
|
Cells, Cultured | 12 | 2018 | 19015 | 0.110 |
Why?
|
Lentivirus | 1 | 2016 | 518 | 0.110 |
Why?
|
Receptors, AMPA | 1 | 2015 | 334 | 0.110 |
Why?
|
Rabbits | 14 | 1994 | 4772 | 0.110 |
Why?
|
Organophosphorus Compounds | 1 | 1994 | 211 | 0.110 |
Why?
|
Antitubercular Agents | 1 | 2022 | 1397 | 0.110 |
Why?
|
Shock, Septic | 5 | 1995 | 774 | 0.110 |
Why?
|
Ibuprofen | 3 | 1989 | 229 | 0.100 |
Why?
|
Lassa Fever | 1 | 2014 | 97 | 0.100 |
Why?
|
Interleukin-2 | 3 | 1995 | 1895 | 0.100 |
Why?
|
Erythrocyte Count | 1 | 2013 | 157 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3115 | 0.100 |
Why?
|
Humans | 69 | 2023 | 768166 | 0.100 |
Why?
|
Antigens, Bacterial | 1 | 2018 | 1150 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 3 | 2018 | 3740 | 0.100 |
Why?
|
Sepsis | 4 | 1994 | 2608 | 0.100 |
Why?
|
Complement System Proteins | 4 | 1991 | 738 | 0.100 |
Why?
|
Urinary Tract Infections | 1 | 2018 | 804 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1238 | 0.100 |
Why?
|
Laser Therapy | 1 | 2018 | 1107 | 0.090 |
Why?
|
Encephalitis | 1 | 2015 | 441 | 0.090 |
Why?
|
Urinary Bladder | 1 | 1997 | 1157 | 0.090 |
Why?
|
Orthomyxoviridae Infections | 1 | 2013 | 255 | 0.090 |
Why?
|
Radioimmunoassay | 9 | 1993 | 863 | 0.090 |
Why?
|
Bacterial Proteins | 2 | 2014 | 3840 | 0.090 |
Why?
|
Pregnadienes | 2 | 1983 | 24 | 0.090 |
Why?
|
Danazol | 2 | 1983 | 44 | 0.090 |
Why?
|
Wounds and Injuries | 3 | 1995 | 2517 | 0.090 |
Why?
|
Influenza A virus | 1 | 2013 | 460 | 0.090 |
Why?
|
Animals | 42 | 2019 | 169246 | 0.080 |
Why?
|
Immune Tolerance | 1 | 2019 | 2323 | 0.080 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 1995 | 621 | 0.080 |
Why?
|
Ovarian Neoplasms | 2 | 2019 | 4916 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1883 | 0.080 |
Why?
|
Autoantibodies | 2 | 2015 | 2121 | 0.080 |
Why?
|
Blood Coagulation | 1 | 1995 | 1162 | 0.080 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 6 | 2004 | 299 | 0.080 |
Why?
|
Escherichia coli | 6 | 2018 | 4214 | 0.080 |
Why?
|
Blood Platelets | 2 | 1997 | 2479 | 0.080 |
Why?
|
Viral Vaccines | 1 | 2014 | 596 | 0.080 |
Why?
|
Gene Expression | 3 | 2004 | 7598 | 0.080 |
Why?
|
Angioedema | 6 | 1994 | 184 | 0.070 |
Why?
|
Female | 38 | 2020 | 397192 | 0.070 |
Why?
|
Benzylamines | 2 | 2019 | 251 | 0.070 |
Why?
|
Biocompatible Materials | 1 | 1996 | 1702 | 0.070 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2007 | 59 | 0.070 |
Why?
|
Cell Movement | 3 | 2018 | 5210 | 0.070 |
Why?
|
Antigen-Presenting Cells | 1 | 2010 | 960 | 0.070 |
Why?
|
Genetic Vectors | 1 | 2016 | 3402 | 0.070 |
Why?
|
Hypotension | 2 | 1993 | 888 | 0.070 |
Why?
|
Thiazoles | 1 | 1994 | 1542 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3603 | 0.070 |
Why?
|
Antigens, Neoplasm | 1 | 2014 | 1997 | 0.070 |
Why?
|
Oxygen | 2 | 2019 | 4270 | 0.070 |
Why?
|
Occupational Exposure | 1 | 2016 | 1807 | 0.070 |
Why?
|
Hemodynamics | 7 | 1995 | 4194 | 0.070 |
Why?
|
Dental Implants | 2 | 1992 | 807 | 0.060 |
Why?
|
Receptor, Anaphylatoxin C5a | 2 | 2004 | 87 | 0.060 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3948 | 0.060 |
Why?
|
Immunoglobulin M | 2 | 2020 | 1528 | 0.060 |
Why?
|
Bacillus | 1 | 2005 | 77 | 0.060 |
Why?
|
Drug Approval | 1 | 2012 | 821 | 0.060 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2005 | 95 | 0.060 |
Why?
|
Telepathology | 1 | 2005 | 77 | 0.060 |
Why?
|
Mice | 18 | 2019 | 82029 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3814 | 0.060 |
Why?
|
Pilot Projects | 1 | 2018 | 8741 | 0.060 |
Why?
|
Mycobacterium smegmatis | 1 | 2005 | 126 | 0.060 |
Why?
|
Fever | 4 | 2007 | 1614 | 0.060 |
Why?
|
Mice, Inbred C57BL | 9 | 2018 | 22379 | 0.060 |
Why?
|
Pertussis Toxin | 1 | 2004 | 176 | 0.060 |
Why?
|
Drug Discovery | 1 | 2012 | 1068 | 0.060 |
Why?
|
Cytokines | 3 | 1995 | 7453 | 0.060 |
Why?
|
Neutrophils | 5 | 1994 | 3786 | 0.060 |
Why?
|
Pyridines | 1 | 1996 | 2894 | 0.060 |
Why?
|
Interferon-gamma | 2 | 2014 | 3160 | 0.060 |
Why?
|
Macrophage-1 Antigen | 1 | 2004 | 286 | 0.050 |
Why?
|
Antiprotozoal Agents | 2 | 2008 | 95 | 0.050 |
Why?
|
Osmolar Concentration | 1 | 2004 | 657 | 0.050 |
Why?
|
Health Personnel | 1 | 2016 | 3385 | 0.050 |
Why?
|
Vaginal Smears | 1 | 2005 | 505 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2022 | 11519 | 0.050 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2005 | 392 | 0.050 |
Why?
|
Complement C1 Inactivator Proteins | 3 | 1994 | 89 | 0.050 |
Why?
|
Bacteroides fragilis | 2 | 1985 | 250 | 0.050 |
Why?
|
Blood Pressure | 5 | 1993 | 8543 | 0.050 |
Why?
|
Mice, Inbred BALB C | 4 | 2018 | 6231 | 0.050 |
Why?
|
Cytosol | 1 | 2004 | 887 | 0.050 |
Why?
|
Complement C4 | 5 | 1983 | 216 | 0.040 |
Why?
|
Male | 25 | 2020 | 364719 | 0.040 |
Why?
|
Middle Aged | 13 | 2020 | 223492 | 0.040 |
Why?
|
Sodium Azide | 1 | 2019 | 24 | 0.040 |
Why?
|
Abetalipoproteinemia | 1 | 2019 | 16 | 0.040 |
Why?
|
Adult | 20 | 2020 | 223646 | 0.040 |
Why?
|
Chromatography, Affinity | 1 | 2020 | 525 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2020 | 404 | 0.040 |
Why?
|
Shock | 3 | 1991 | 316 | 0.040 |
Why?
|
DNA Primers | 2 | 2010 | 2828 | 0.040 |
Why?
|
Immunity, Innate | 3 | 2020 | 3080 | 0.040 |
Why?
|
Singlet Oxygen | 1 | 2018 | 58 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2020 | 1065 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4568 | 0.040 |
Why?
|
Biotechnology | 1 | 2020 | 283 | 0.040 |
Why?
|
Arachnid Vectors | 1 | 1998 | 24 | 0.040 |
Why?
|
Dose-Response Relationship, Immunologic | 3 | 1992 | 361 | 0.040 |
Why?
|
Mice, Inbred DBA | 3 | 2006 | 624 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2005 | 2202 | 0.040 |
Why?
|
Cell Line | 2 | 2020 | 15597 | 0.040 |
Why?
|
Cell Adhesion | 3 | 1998 | 3096 | 0.040 |
Why?
|
RNA, Messenger | 5 | 1998 | 12800 | 0.040 |
Why?
|
T-Lymphocytes | 2 | 1994 | 10266 | 0.040 |
Why?
|
Ticks | 1 | 1998 | 71 | 0.040 |
Why?
|
Wound Healing | 1 | 1989 | 2809 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 59629 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14729 | 0.040 |
Why?
|
Young Adult | 3 | 2020 | 60066 | 0.040 |
Why?
|
Mannose-Binding Lectins | 1 | 2017 | 101 | 0.030 |
Why?
|
Immunoassay | 1 | 2020 | 746 | 0.030 |
Why?
|
Wounds, Nonpenetrating | 2 | 1995 | 807 | 0.030 |
Why?
|
Cell Degranulation | 1 | 1997 | 277 | 0.030 |
Why?
|
Fibroblasts | 1 | 1987 | 4176 | 0.030 |
Why?
|
Complement C4a | 1 | 1996 | 14 | 0.030 |
Why?
|
Receptors, CCR2 | 1 | 2017 | 216 | 0.030 |
Why?
|
Rats | 5 | 2018 | 23760 | 0.030 |
Why?
|
Cricetulus | 1 | 2018 | 812 | 0.030 |
Why?
|
Alkylation | 1 | 1996 | 84 | 0.030 |
Why?
|
Ixodes | 1 | 1996 | 40 | 0.030 |
Why?
|
Leukocyte Count | 4 | 1994 | 1609 | 0.030 |
Why?
|
Arthroscopy | 1 | 2022 | 971 | 0.030 |
Why?
|
Adsorption | 1 | 1996 | 198 | 0.030 |
Why?
|
Signal Transduction | 1 | 2019 | 23645 | 0.030 |
Why?
|
Indomethacin | 1 | 1996 | 323 | 0.030 |
Why?
|
Candidiasis | 1 | 1978 | 367 | 0.030 |
Why?
|
Binding Sites | 1 | 2004 | 6020 | 0.030 |
Why?
|
Insect Vectors | 1 | 1996 | 136 | 0.030 |
Why?
|
CHO Cells | 1 | 2018 | 1379 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2018 | 740 | 0.030 |
Why?
|
Up-Regulation | 1 | 2004 | 4146 | 0.030 |
Why?
|
Pyrogens | 1 | 1994 | 17 | 0.030 |
Why?
|
Ribosomes | 1 | 2018 | 497 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2019 | 591 | 0.030 |
Why?
|
Complement C3 | 3 | 1991 | 434 | 0.030 |
Why?
|
Edetic Acid | 1 | 1995 | 278 | 0.030 |
Why?
|
Blood Bactericidal Activity | 2 | 1987 | 124 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2019 | 3703 | 0.030 |
Why?
|
Cats | 1 | 1996 | 978 | 0.030 |
Why?
|
Escherichia coli Infections | 1 | 2018 | 524 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 1995 | 400 | 0.030 |
Why?
|
HLA-DR3 Antigen | 1 | 2014 | 24 | 0.030 |
Why?
|
Immunization | 1 | 2018 | 1219 | 0.030 |
Why?
|
Cricetinae | 1 | 2018 | 2423 | 0.030 |
Why?
|
Tyrosine | 1 | 2018 | 1427 | 0.030 |
Why?
|
Thrombin | 1 | 1997 | 600 | 0.030 |
Why?
|
C-Reactive Protein | 4 | 1991 | 3858 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2004 | 10760 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 594 | 0.030 |
Why?
|
Platelet Count | 2 | 1994 | 787 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6082 | 0.030 |
Why?
|
Vagina | 1 | 2019 | 850 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2018 | 733 | 0.030 |
Why?
|
Syphilis | 1 | 1976 | 243 | 0.030 |
Why?
|
Bacteroides Infections | 2 | 1985 | 89 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9561 | 0.030 |
Why?
|
Computational Biology | 1 | 2005 | 3568 | 0.030 |
Why?
|
Interleukin-8 | 2 | 1993 | 704 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4580 | 0.030 |
Why?
|
Hepatitis | 1 | 1995 | 227 | 0.030 |
Why?
|
Lassa virus | 1 | 2014 | 99 | 0.030 |
Why?
|
Penicillins | 1 | 1976 | 406 | 0.030 |
Why?
|
Russia | 1 | 2014 | 386 | 0.030 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2005 | 2043 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2017 | 1617 | 0.030 |
Why?
|
Granuloma | 1 | 1995 | 329 | 0.030 |
Why?
|
Surface Properties | 1 | 1996 | 1166 | 0.030 |
Why?
|
Multiple Organ Failure | 1 | 1995 | 388 | 0.030 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18349 | 0.030 |
Why?
|
Serum Albumin | 1 | 1996 | 677 | 0.030 |
Why?
|
Adolescent | 6 | 2018 | 89169 | 0.020 |
Why?
|
Macrophage Activation | 1 | 1995 | 557 | 0.020 |
Why?
|
Base Sequence | 2 | 2010 | 12421 | 0.020 |
Why?
|
Ovalbumin | 1 | 2014 | 677 | 0.020 |
Why?
|
Aged | 10 | 2020 | 171504 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 17140 | 0.020 |
Why?
|
Pulmonary Surfactants | 2 | 1989 | 169 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 1994 | 408 | 0.020 |
Why?
|
Leishmaniasis, Visceral | 1 | 1992 | 100 | 0.020 |
Why?
|
Hemorrhage | 2 | 1995 | 3467 | 0.020 |
Why?
|
Cell Separation | 1 | 1997 | 1728 | 0.020 |
Why?
|
Dogs | 1 | 1996 | 3845 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6340 | 0.020 |
Why?
|
Calcium | 1 | 2004 | 5792 | 0.020 |
Why?
|
Choline | 2 | 1989 | 522 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2018 | 1063 | 0.020 |
Why?
|
Cattle | 1 | 1996 | 3819 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1996 | 3055 | 0.020 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 1 | 1989 | 40 | 0.020 |
Why?
|
Occupational Health | 1 | 2016 | 812 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8748 | 0.020 |
Why?
|
Protein Engineering | 1 | 2014 | 553 | 0.020 |
Why?
|
Mice, SCID | 2 | 2006 | 2627 | 0.020 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2014 | 452 | 0.020 |
Why?
|
Massachusetts | 2 | 2020 | 8890 | 0.020 |
Why?
|
Phosphorylcholine | 1 | 1989 | 153 | 0.020 |
Why?
|
Osseointegration | 1 | 1991 | 277 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13586 | 0.020 |
Why?
|
Meningococcal Infections | 1 | 1989 | 78 | 0.020 |
Why?
|
Polymyxin B | 1 | 1988 | 44 | 0.020 |
Why?
|
Serum Amyloid P-Component | 1 | 1988 | 46 | 0.020 |
Why?
|
Pancreatic Elastase | 1 | 1988 | 125 | 0.020 |
Why?
|
Plasmapheresis | 1 | 1989 | 206 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2022 | 81762 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8542 | 0.020 |
Why?
|
Pseudomonas | 1 | 1988 | 124 | 0.020 |
Why?
|
Methotrexate | 1 | 1995 | 1721 | 0.020 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1988 | 317 | 0.020 |
Why?
|
Lyme Disease | 1 | 1994 | 630 | 0.020 |
Why?
|
Interleukin-6 | 1 | 1998 | 3228 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6395 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2014 | 1801 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1989 | 760 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1996 | 6229 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12077 | 0.020 |
Why?
|
Spherocytosis, Hereditary | 1 | 2007 | 83 | 0.020 |
Why?
|
Blood Transfusion | 2 | 1993 | 1309 | 0.020 |
Why?
|
Muramidase | 1 | 1987 | 163 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3886 | 0.020 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 1989 | 361 | 0.020 |
Why?
|
Zoonoses | 1 | 2008 | 180 | 0.020 |
Why?
|
Heart | 1 | 2020 | 4446 | 0.020 |
Why?
|
Quinolinium Compounds | 1 | 2006 | 10 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 2 | 1987 | 660 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 1995 | 1892 | 0.020 |
Why?
|
Hematologic Tests | 1 | 2007 | 239 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1994 | 6124 | 0.020 |
Why?
|
Superoxides | 1 | 1987 | 389 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4283 | 0.020 |
Why?
|
Chromatography, Gas | 1 | 2005 | 150 | 0.020 |
Why?
|
Immunity, Cellular | 2 | 1984 | 1561 | 0.020 |
Why?
|
Vascular Resistance | 1 | 1989 | 939 | 0.020 |
Why?
|
Splenectomy | 1 | 2007 | 392 | 0.020 |
Why?
|
Biopsy | 1 | 1997 | 6793 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 1995 | 17622 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 1994 | 1240 | 0.020 |
Why?
|
Benzoxazoles | 1 | 2006 | 92 | 0.020 |
Why?
|
Spleen | 2 | 2004 | 2295 | 0.020 |
Why?
|
Aging | 1 | 2004 | 8744 | 0.020 |
Why?
|
Recurrence | 2 | 2008 | 8509 | 0.010 |
Why?
|
Complement C3b | 1 | 1984 | 98 | 0.010 |
Why?
|
Receptors, Transferrin | 1 | 2006 | 300 | 0.010 |
Why?
|
Biological Assay | 1 | 1987 | 628 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1972 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6526 | 0.010 |
Why?
|
Lymphatic Diseases | 1 | 2006 | 319 | 0.010 |
Why?
|
Kinetics | 4 | 1994 | 6329 | 0.010 |
Why?
|
Lymphocytes | 1 | 1991 | 2614 | 0.010 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1983 | 42 | 0.010 |
Why?
|
Parasitemia | 1 | 2004 | 166 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6847 | 0.010 |
Why?
|
Zymosan | 1 | 1983 | 134 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1990 | 2094 | 0.010 |
Why?
|
Complement Pathway, Classical | 1 | 1982 | 91 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10399 | 0.010 |
Why?
|
Automation | 1 | 2005 | 589 | 0.010 |
Why?
|
Hemophilia B | 1 | 1983 | 83 | 0.010 |
Why?
|
Mycobacterium tuberculosis | 1 | 2014 | 1930 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2008 | 863 | 0.010 |
Why?
|
Elapid Venoms | 2 | 1980 | 40 | 0.010 |
Why?
|
Critical Care | 1 | 1995 | 2715 | 0.010 |
Why?
|
Magnesium Chloride | 1 | 1981 | 30 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 1993 | 3044 | 0.010 |
Why?
|
Diagnosis, Differential | 3 | 2007 | 13014 | 0.010 |
Why?
|
Egtazic Acid | 1 | 1981 | 166 | 0.010 |
Why?
|
Cervix Uteri | 1 | 2005 | 577 | 0.010 |
Why?
|
Lymphokines | 1 | 1984 | 924 | 0.010 |
Why?
|
Phagocytosis | 1 | 1987 | 1530 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10101 | 0.010 |
Why?
|
Bacteroides | 1 | 1981 | 165 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2014 | 4415 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 1993 | 4427 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10590 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 1995 | 3187 | 0.010 |
Why?
|
Body Temperature | 2 | 1994 | 780 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2022 | 15832 | 0.010 |
Why?
|
Hemophilia A | 1 | 1983 | 359 | 0.010 |
Why?
|
Species Specificity | 1 | 2004 | 2415 | 0.010 |
Why?
|
Papillomaviridae | 1 | 2005 | 1140 | 0.010 |
Why?
|
Dyspnea | 1 | 2007 | 1352 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 1987 | 1430 | 0.010 |
Why?
|
Complement Activating Enzymes | 1 | 1978 | 22 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1995 | 4282 | 0.010 |
Why?
|
Sialic Acids | 1 | 1979 | 123 | 0.010 |
Why?
|
Time Factors | 5 | 1992 | 40218 | 0.010 |
Why?
|
Neuraminidase | 1 | 1979 | 195 | 0.010 |
Why?
|
Tritium | 2 | 1989 | 707 | 0.010 |
Why?
|
Syndrome | 2 | 1993 | 3272 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2005 | 1489 | 0.010 |
Why?
|
Mitogens | 1 | 1998 | 229 | 0.010 |
Why?
|
Magnesium | 1 | 1981 | 815 | 0.010 |
Why?
|
Incidence | 2 | 1994 | 21538 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6316 | 0.010 |
Why?
|
Energy Metabolism | 1 | 1988 | 2907 | 0.010 |
Why?
|
Esterases | 1 | 1976 | 89 | 0.010 |
Why?
|
Melanoma | 1 | 1995 | 5706 | 0.010 |
Why?
|
Hemolysis | 1 | 1979 | 417 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1990 | 7608 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1978 | 1310 | 0.010 |
Why?
|
Abscess | 1 | 1980 | 606 | 0.010 |
Why?
|
Treponema pallidum | 1 | 1976 | 48 | 0.010 |
Why?
|
Radiography | 1 | 2007 | 6983 | 0.010 |
Why?
|
Proteins | 1 | 1991 | 6009 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2006 | 5902 | 0.010 |
Why?
|
Antigens, CD | 1 | 2006 | 4035 | 0.010 |
Why?
|
Risk Factors | 1 | 2022 | 74944 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1976 | 642 | 0.010 |
Why?
|
Candida albicans | 1 | 1978 | 375 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 24315 | 0.010 |
Why?
|
Menstruation | 1 | 1976 | 310 | 0.010 |
Why?
|
Erythema | 1 | 1976 | 261 | 0.010 |
Why?
|
Digestive System | 1 | 1995 | 244 | 0.010 |
Why?
|
Adhesiveness | 1 | 1994 | 52 | 0.010 |
Why?
|
Erythrocyte Deformability | 1 | 1994 | 55 | 0.010 |
Why?
|
Quinine | 1 | 1994 | 51 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2005 | 5315 | 0.010 |
Why?
|
Neoplasms | 2 | 2014 | 22371 | 0.010 |
Why?
|
Clindamycin | 1 | 1994 | 138 | 0.010 |
Why?
|
Permeability | 1 | 1995 | 725 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39348 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2005 | 1640 | 0.010 |
Why?
|
Receptors, Complement | 1 | 1994 | 254 | 0.010 |
Why?
|
Inflammation | 1 | 1993 | 10873 | 0.010 |
Why?
|
Internet | 1 | 2005 | 3110 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1994 | 365 | 0.010 |
Why?
|
Umbilical Veins | 1 | 1993 | 424 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2017 | 65371 | 0.010 |
Why?
|
Acute Disease | 2 | 1994 | 7243 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1992 | 305 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 1993 | 422 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 1993 | 260 | 0.010 |
Why?
|
Burn Units | 1 | 1992 | 143 | 0.010 |
Why?
|
Body Surface Area | 1 | 1992 | 205 | 0.010 |
Why?
|
Immune Sera | 1 | 1992 | 605 | 0.010 |
Why?
|
Complement Membrane Attack Complex | 1 | 1991 | 105 | 0.010 |
Why?
|
Skin Diseases | 1 | 1980 | 1085 | 0.010 |
Why?
|
Pneumonia | 1 | 1983 | 2163 | 0.010 |
Why?
|
Mucus | 1 | 1993 | 346 | 0.010 |
Why?
|
Teichoic Acids | 1 | 1991 | 70 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1983 | 2257 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2230 | 0.010 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 1990 | 221 | 0.010 |
Why?
|
Liver | 2 | 1994 | 7577 | 0.010 |
Why?
|
Listeria monocytogenes | 1 | 1992 | 246 | 0.010 |
Why?
|
Child | 3 | 1995 | 80917 | 0.010 |
Why?
|
Surface Tension | 1 | 1989 | 43 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 22291 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1995 | 1196 | 0.010 |
Why?
|
Autoantigens | 1 | 1994 | 890 | 0.010 |
Why?
|
Epinephrine | 1 | 1993 | 794 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1990 | 826 | 0.010 |
Why?
|
Rectum | 1 | 1994 | 900 | 0.010 |
Why?
|
Cell Membrane | 1 | 1979 | 3655 | 0.010 |
Why?
|
Organ Specificity | 1 | 1994 | 1968 | 0.010 |
Why?
|
Sex Factors | 1 | 1983 | 10632 | 0.010 |
Why?
|
Glycoproteins | 1 | 1976 | 2202 | 0.000 |
Why?
|
Neisseria meningitidis | 1 | 1989 | 111 | 0.000 |
Why?
|
Pulse | 1 | 1988 | 218 | 0.000 |
Why?
|
Headache | 1 | 1976 | 1263 | 0.000 |
Why?
|
Brain | 1 | 2015 | 27360 | 0.000 |
Why?
|
alpha 1-Antitrypsin | 1 | 1988 | 169 | 0.000 |
Why?
|
Hospitals, General | 1 | 1992 | 809 | 0.000 |
Why?
|
Epitopes | 1 | 1994 | 2528 | 0.000 |
Why?
|
Carbon Radioisotopes | 1 | 1988 | 567 | 0.000 |
Why?
|
Fluid Therapy | 1 | 1991 | 587 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2005 | 20227 | 0.000 |
Why?
|
Administration, Oral | 1 | 1995 | 4030 | 0.000 |
Why?
|
Necrosis | 1 | 1991 | 1616 | 0.000 |
Why?
|
Spectrometry, Fluorescence | 1 | 1989 | 694 | 0.000 |
Why?
|
Glucagon | 1 | 1988 | 535 | 0.000 |
Why?
|
Immunotherapy | 2 | 1993 | 4755 | 0.000 |
Why?
|
Bacteremia | 1 | 1993 | 986 | 0.000 |
Why?
|
Body Weight | 1 | 1976 | 4627 | 0.000 |
Why?
|
Iodine Radioisotopes | 1 | 1989 | 1034 | 0.000 |
Why?
|
Cell Communication | 1 | 1993 | 1660 | 0.000 |
Why?
|
Liposomes | 1 | 1989 | 790 | 0.000 |
Why?
|
United States | 1 | 2014 | 73039 | 0.000 |
Why?
|
Reference Values | 1 | 1992 | 4938 | 0.000 |
Why?
|
Carbon Dioxide | 1 | 1988 | 1148 | 0.000 |
Why?
|
Amyloid | 1 | 1988 | 854 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1994 | 8128 | 0.000 |
Why?
|
Kidney | 1 | 1978 | 7064 | 0.000 |
Why?
|
Respiration, Artificial | 1 | 1994 | 2726 | 0.000 |
Why?
|
Liver Diseases | 1 | 1991 | 1305 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1988 | 2227 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1994 | 13421 | 0.000 |
Why?
|
Oxygen Consumption | 1 | 1988 | 1880 | 0.000 |
Why?
|
Respiration | 1 | 1988 | 1665 | 0.000 |
Why?
|
Peptides | 1 | 1994 | 4354 | 0.000 |
Why?
|
Swine | 1 | 1991 | 5995 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1989 | 1841 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1976 | 8054 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1991 | 5505 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1980 | 396 | 0.000 |
Why?
|
Cecum | 1 | 1980 | 231 | 0.000 |
Why?
|
Prospective Studies | 2 | 1995 | 54926 | 0.000 |
Why?
|
Macaca mulatta | 1 | 1985 | 2363 | 0.000 |
Why?
|
Survival Rate | 1 | 1992 | 12840 | 0.000 |
Why?
|
Glucose | 1 | 1988 | 4352 | 0.000 |
Why?
|
Methyltestosterone | 1 | 1976 | 19 | 0.000 |
Why?
|
Complement Inactivator Proteins | 1 | 1976 | 74 | 0.000 |
Why?
|
DNA | 1 | 1989 | 7214 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 1992 | 15948 | 0.000 |
Why?
|
Insulin | 1 | 1988 | 6607 | 0.000 |
Why?
|
Mice, Nude | 1 | 1980 | 3623 | 0.000 |
Why?
|
Tranexamic Acid | 1 | 1976 | 174 | 0.000 |
Why?
|
Progesterone | 1 | 1976 | 752 | 0.000 |
Why?
|
Prognosis | 1 | 1992 | 30010 | 0.000 |
Why?
|
Child, Preschool | 1 | 1992 | 42669 | 0.000 |
Why?
|
Pedigree | 1 | 1976 | 4539 | 0.000 |
Why?
|
Intubation, Intratracheal | 1 | 1976 | 1359 | 0.000 |
Why?
|
Pregnancy | 1 | 1976 | 30256 | 0.000 |
Why?
|